Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study

References

• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.28431
   PubMed Web of Science ®Google Scholar
• Liu J, Ayada I, Zhang X, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2022;20(3):e573–e582. doi:10.1016/j.cgh.2021.02.030
   PubMed Web of Science ®Google Scholar
• Yamamura S, Eslam M, Kawaguchi T, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40(12):3018–3030. doi:10.1111/liv.14675
   PubMed Web of Science ®Google Scholar
• Chen VL, Yeh ML, Yang JD, et al. Effects of cirrhosis and diagnosis scenario in metabolic-associated fatty liver disease-related hepatocellular carcinoma. Hepatol Commun. 2021;5(1):122–132. doi:10.1002/hep4.1606
   PubMed Web of Science ®Google Scholar
• Lei F, Qin JJ, Song X, et al. The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China. Front Endocrinol. 2022;13:1007171. doi:10.3389/fendo.2022.1007171
   PubMed Web of Science ®Google Scholar
• Yoneda M, Yamamoto T, Honda Y, et al. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan. J Gastroenterol. 2021;56(11):1022–1032. doi:10.1007/s00535-021-01828-6
   PubMed Web of Science ®Google Scholar
• Xie ZQ, Li HX, Wang BK, et al. Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: results from the NHANES study. Eur J Intern Med. 2023;110:62–70. doi:10.1016/j.ejim.2023.01.029
   PubMed Web of Science ®Google Scholar
• Kim D, Konyn P, Sandhu KK, et al. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol. 2021;75(6):1284–1291. doi:10.1016/j.jhep.2021.07.035
   PubMed Web of Science ®Google Scholar
• Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol. 2018;14(5):259–269. doi:10.1038/nrendo.2018.10
   PubMed Web of Science ®Google Scholar
• Xu C, Xu L, Yu C, et al. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol. 2011;75(2):240–246. doi:10.1111/j.1365-2265.2011.04016.x
   PubMed Web of Science ®Google Scholar
• Ludwig U, Holzner D, Denzer C, et al. Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. BMC Endocr Disord. 2015;15(1):41. doi:10.1186/s12902-015-0030-5
   PubMedGoogle Scholar
• Chung GE, Kim D, Kim W, et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol. 2012;57(1):150–156. doi:10.1016/j.jhep.2012.02.027
   PubMed Web of Science ®Google Scholar
• Tao Y, Gu H, Wu J, et al. Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects. Endocr Res. 2015;40(2):74–78. doi:10.3109/07435800.2014.952014
   PubMed Web of Science ®Google Scholar
• Ittermann T, Haring R, Wallaschofski H, et al. Inverse association between serum free thyroxine levels and hepatic steatosis: results from the study of health in Pomerania. Thyroid. 2012;22(6):568–574. doi:10.1089/thy.2011.0279
   PubMed Web of Science ®Google Scholar
• Hu DS, Zhu SH, Liu WY, et al. PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD. Diabetes Metab. 2020;46(6):496–503. doi:10.1016/j.diabet.2020.02.001
   PubMed Web of Science ®Google Scholar
• Guo W, Qin P, Li XN, et al. Free triiodothyronine is associated with hepatic steatosis and liver stiffness in euthyroid Chinese adults with non-alcoholic fatty liver disease. Front Endocrinol. 2021;12:711956. doi:10.3389/fendo.2021.711956
   PubMed Web of Science ®Google Scholar
• Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care. 2019;42(2):303–310. doi:10.2337/dc18-1410
   PubMed Web of Science ®Google Scholar
• Corica D, Licenziati MR, Calcaterra V, et al. Central and peripheral sensitivity to thyroid hormones and glucose metabolism in prepubertal children with obesity: pilot multicenter evaluation. Endocrine. 2023;80(2):308–311. doi:10.1007/s12020-022-03276-5
   PubMed Web of Science ®Google Scholar
• Li R, Zhou L, Chen C, et al. Sensitivity to thyroid hormones is associated with advanced fibrosis in euthyroid patients with non-alcoholic fatty liver disease: a cross-sectional study. Dig Liver Dis. 2023;55(2):254–261. doi:10.1016/j.dld.2022.06.021
   PubMedGoogle Scholar
• Yang S, Lai S, Wang Z, et al. Thyroid feedback quantile-based index correlates strongly to renal function in euthyroid individuals. Ann Med. 2021;53(1):1945–1955. doi:10.1080/07853890.2021.1993324
   PubMed Web of Science ®Google Scholar
• Sun H, Zhu W, Liu J, et al. Reduced sensitivity to thyroid hormones is associated with high remnant cholesterol levels in Chinese euthyroid adults. J Clin Endocrinol Metab. 2022;108(1):166–174. doi:10.1210/clinem/dgac523
   PubMedGoogle Scholar
• Mehran L, Delbari N, Amouzegar A, et al. Reduced sensitivity to thyroid hormone is associated with diabetes and hypertension. J Clin Endocrinol Metab. 2022;107(1):167–176. doi:10.1210/clinem/dgab646
   PubMed Web of Science ®Google Scholar
• Gökmen FY, Ahbab S, Ataoğlu HE, et al. FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism. Clinics. 2016;71(4):221–225. doi:10.6061/clinics/2016(04)08
   PubMed Web of Science ®Google Scholar
• Lai S, Li J, Wang Z, et al. Sensitivity to thyroid hormone indices are closely associated with NAFLD. Front Endocrinol. 2021;12:766419. doi:10.3389/fendo.2021.766419
   PubMed Web of Science ®Google Scholar
• Yagi H, Pohlenz J, Hayashi Y, et al. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3’-triiodothyroinine binding affinity. J Clin Endocrinol Metab. 1997;82(5):1608–1614. doi:10.1210/jcem.82.5.3945
   PubMed Web of Science ®Google Scholar
• Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH index. Clin Endocrinol. 2009;71(4):529–534. doi:10.1111/j.1365-2265.2009.03534.x
   PubMed Web of Science ®Google Scholar
• Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15. doi:10.1186/s12944-017-0409-6
   PubMedGoogle Scholar
• Zhang X, Chen Y, Ye H, et al. Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes. Endocrine. 2023;80(2):366–379. doi:10.1007/s12020-022-03279-2
   PubMed Web of Science ®Google Scholar
• Chen YL, Tian S, Wu J, et al. Impact of thyroid function on the prevalence and mortality of metabolic dysfunction-associated fatty liver disease. J Clin Endocrinol Metab. 2023;108(7):e434–e443. doi:10.1210/clinem/dgad016
   PubMed Web of Science ®Google Scholar
• Marschner RA, Arenhardt F, Ribeiro RT, et al. Influence of altered thyroid hormone mechanisms in the progression of metabolic dysfunction associated with fatty liver disease (MAFLD): a systematic review. Metabolites. 2022;12(8):675. doi:10.3390/metabo12080675
   PubMed Web of Science ®Google Scholar
• Wan H, Yu G, Xu S, et al. Central sensitivity to free triiodothyronine with MAFLD and its progression to liver fibrosis in euthyroid adults. J Clin Endocrinol Metab. 2023. doi:10.1210/clinem/dgad186
   Web of Science ®Google Scholar
• Correa-Rodriguez M, Gonzalez-Jimenez E, Fernandez-Aparicio A, et al. Dietary energy density is associated with body mass index and fat mass in early adulthood. Clin Nurs Res. 2021;30(5):591–598. doi:10.1177/1054773819883192
   PubMed Web of Science ®Google Scholar
• Bektur AN, Sahin E, Kacar S, et al. Investigation of the effect of hyperthyroidism on endoplasmic reticulum stress and tran-sient receptor potential canonical 1 channel in the kidney. Turk J Med Sci. 2021;51(3):1554–1563. doi:10.3906/sag-2007-109
   PubMed Web of Science ®Google Scholar
• Lim S, Kim JW, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2021;32(7):500–514. doi:10.1016/j.tem.2021.04.008
   PubMed Web of Science ®Google Scholar
• Taylor PN, Razvi S, Pearce SH, et al. Clinical review: a review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013;98(9):3562–3571. doi:10.1210/jc.2013-1315
   PubMed Web of Science ®Google Scholar
• Sinha RA, Yen PM. Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD. Cell Biosci. 2016;6(1):46. doi:10.1186/s13578-016-0113-7
   PubMedGoogle Scholar
• van Tienhoven-Wind LJ, Dullaart RP. Tumor necrosis factor-alpha is inversely related to free thyroxine in euthyroid subjects without diabetes. Horm Metab Res. 2017;49(2):95–102. doi:10.1055/s-0042-119211
   PubMed Web of Science ®Google Scholar
• Marchiori RC, Pereira LA, Naujorks AA, et al. Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment. BMC Endocr Disord. 2015;15:32. doi:10.1186/s12902-015-0032-3
   PubMed Web of Science ®Google Scholar
• Milani AT, Khadem-Ansari MH, Rasmi Y. Effects of thyroxine on adhesion molecules and proinflammatory cytokines secretion on human umbilical vein endothelial cells. Res Pharm Sci. 2019;14(3):237–246. doi:10.4103/1735-5362.258490
   PubMed Web of Science ®Google Scholar
• Souza-Mello V. Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. World J Hepatol. 2015;7(8):1012–1019. doi:10.4254/wjh.v7.i8.1012
   PubMed Web of Science ®Google Scholar
• Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48(4):634–642. doi:10.1007/s00125-005-1682-x
   PubMed Web of Science ®Google Scholar
• Könner AC, Brüning JC. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab. 2011;22(1):16–23. doi:10.1016/j.tem.2010.08.007
   PubMed Web of Science ®Google Scholar
• Hribal ML, Procopio T, Petta S, et al. Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2013;98(2):E304–E308. doi:10.1210/jc.2012-3290
   PubMed Web of Science ®Google Scholar
• Filali-Mouncef Y, Hunter C, Roccio F, et al. The ménage à trois of autophagy, lipid droplets and liver disease. Autophagy. 2022;18(1):50–72. doi:10.1080/15548627.2021.1895658
   PubMed Web of Science ®Google Scholar
• Lebeaupin C, Vallee D, Hazari Y, et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):927–947. doi:10.1016/j.jhep.2018.06.008
   PubMed Web of Science ®Google Scholar
• Kammoun HL, Chabanon H, Hainault I, et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest. 2009;119(5):1201–1215. doi:10.1172/JCI37007
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Kaneto H, Kawamori D, et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem. 2005;280(1):847–851. doi:10.1074/jbc.M411860200
   PubMed Web of Science ®Google Scholar
• Frederiksen L, Brodbaek K, Fenger M, et al. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab. 2002;87(8):3989–3992. doi:10.1210/jcem.87.8.873
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Kubota N, Yamauchi T, et al. Role of insulin resistance in MAFLD. Int J Mol Sci. 2021;22(8):4156. doi:10.3390/ijms22084156
   PubMed Web of Science ®Google Scholar
• Loria P, Lonardo A, Anania F. Liver and diabetes. A vicious circle. Hepatol Res. 2013;43(1):51–64. doi:10.1111/j.1872-034X.2012.01031.x
   PubMed Web of Science ®Google Scholar
• Nie X, Ma X, Xu Y, et al. Increased serum adipocyte fatty acid-binding protein levels are associated with decreased sensitivity to thyroid hormones in the Euthyroid population. Thyroid. 2020;30(12):1718–1723. doi:10.1089/thy.2020.0011
   PubMed Web of Science ®Google Scholar
• Zvibel I, Atias D, Phillips A, et al. Thyroid hormones induce activation of rat hepatic stellate cells through increased expression of p75 neurotrophin receptor and direct activation of Rho. Lab Invest. 2010;90(5):674–684. doi:10.1038/labinvest.2010.48
   PubMed Web of Science ®Google Scholar
• Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304. doi:10.1089/met.2008.0034
   PubMedGoogle Scholar
• Du T, Yuan G, Zhang M, et al. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13(1):146. doi:10.1186/s12933-014-0146-3
   PubMed Web of Science ®Google Scholar
• Low S, Khoo K, Irwan B, et al. The role of triglyceride glucose index in development of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018;143:43–49. doi:10.1016/j.diabres.2018.06.006
   PubMed Web of Science ®Google Scholar
• Zhang R, Guan Q, Zhang M, et al. Association between triglyceride-glucose index and risk of metabolic dysfunction-associated fatty liver disease: a cohort study. Diabetes Metab Syndr Obes. 2022;15:3167–3179. doi:10.2147/DMSO.S383907
   PubMed Web of Science ®Google Scholar
• Taheri E, Pourhoseingholi MA, Moslem A, et al. The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults. J Diabetes Metab Disord. 2022;21(1):97–107. doi:10.1007/s40200-021-00941-w
   PubMed Web of Science ®Google Scholar
• Tutunchi H, Naeini F, Mobasseri M, et al. Triglyceride glucose (TyG) index and the progression of liver fibrosis: a cross-sectional study. Clin Nutr ESPEN. 2021;44:483–487. doi:10.1016/j.clnesp.2021.04.025
   PubMed Web of Science ®Google Scholar
• Sánchez-íñigo L, Navarro-González D, Fernández-Montero A, et al. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–197. doi:10.1111/eci.12583
   PubMed Web of Science ®Google Scholar